0
Article |

Methylene Blue and Light Therapy for Herpes Simplex

Te-Wen Chang, MD; Nicholas Fiumara, MD; Louis Weinstein, MD
Arch Dermatol. 1975;111(2):265-266. doi:10.1001/archderm.1975.01630140123020.
Text Size: A A A
Published online

ABSTRACT

To the Editor.—  Photodynamic inactivation of herpesvirus by methylene blue was demonstrated in our laboratory. About 70% of freshly isolated strains of herpesvirus was found to be highly photosensitive after application of methylene blue at concentration of 105M. Strains resistant to methylene blue were also resistant to neutral red, but were sensitive to proflavine, and vice versa.Our initial clinical trial on patients with recurrent genital herpes indicated that about 70% of 36 individuals treated with methylene blue and light improved: symptoms subsided in 48 hours, and the duration of the illness shortened appreciably. However, the relapse rate was not substantially reduced.Treatment consisted of application of 0.1% methylene blue and, 20 minutes later, exposure to either fluorescent light at a close distance or to sunlight whenever possible. The latter gave a better result. Treatment was carried out at home by the patient. This made treatment possible at

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs